{"nctId":"NCT00621842","briefTitle":"Lamotrigine for Symptoms of Geriatric Bipolar Depression","startDateStruct":{"date":"2008-01"},"conditions":["Bipolar Disorder","Depression, Bipolar"],"count":57,"armGroups":[{"label":"Open-Label Lamotrigine Treatment","type":"EXPERIMENTAL","interventionNames":["Drug: Lamotrigine regular tablet formulation","Drug: Lamotrigine novel formulation"]}],"interventions":[{"name":"Lamotrigine regular tablet formulation","otherNames":["Lamictal"]},{"name":"Lamotrigine novel formulation","otherNames":["Lamictal"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Age 60 Years or older\n* BP Disorder-I or II: Depressive episode (DSM -IV-TR; SCID-I/P)\n* HAM-D score \\> 18 (GRID-HAM-D 24-item version)\n* Availability of an Informant is encouraged but not required for study participation\n\nExclusion Criteria:\n\n* Chronic psychotic conditions, ie. schizophrenia, schizoaffective disorder, delusional disorder\n* Contraindication to lamotrigine (Physician interview, medical assessment)\n* Documented history of intolerance to lamotrigine\n* Patients who have previously failed to respond to at least 12 weeks of treatment with lamotrigine\n* Active substance dependence (SCID-I/P) or substance-related safety issues or PI concerns\n* Mood Disorder Due to a General Medical Condition or Treatment (Physician interview)\n* Rapid cycling (Physician interview): As defined in DSM-IV: At least 4 episodes of mood disturbance in the previous 12 months that meet criteria for a Major Depressive, Manic, Mixed or Hypomanic Episode. Episodes are distinguished either by partial or full remission for at least 2 months or by a switch to an episode of opposite polarity\n* Dementia (by DSM-IV or brain degenerative diseases; Physician interview);\n* Inability to communicate in English (i.e., interview cannot be conducted without an interpreter; subject largely unable to understand questions and cannot respond in English)\n* Clinically significant sensory impairment (i.e., cannot see well enough to read consent or visually-presented material; cannot hear well enough to cooperate with interview; Physician interview)\n* Recent history of cardiovascular, peripheral vascular events or stroke\n* High risk for suicide (e.g., active SI or current intent or plan)\n* Inpatient status","healthyVolunteers":false,"sex":"ALL","minimumAge":"60 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Assessment of Change in Depressive Symptoms From Baseline on the Montgomery Asberg Depression Rating Scale (MADRS)","description":"The minimum possible score is 0 and the maximum score is 60. A higher score implies a worse condition.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-15.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Assessment of Adverse Effects With the Udvalg Fur Kliniske Undersogelser (UKU)","description":"Frequency of adverse effects was measured using the UKU. The total number of adverse effects assessed by the UKU is 49 plus one open-ended question about any adverse effects not assessed.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in Depressive Symptoms From Baseline Using the Hamilton Depression Rating Scale (GRID-HAM-D)","description":"The minimum possible score is 0 and the maximum score is 78. A higher score implies a worse condition.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-15.2","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in Manic Symptoms From Baseline Using the Young Mania Rating Scale (YMRS)","description":"The minimum possible score is 0 and the maximum score is 60. A higher score implies a worse condition.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-.47","spread":null}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in Overall Clinical Diagnosis Using the CGI-BP","description":"The minimum possible score is 1 and the maximum score is 7. A higher score implies a worse condition.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.06","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in or Appearance of Extrapyramidal Symptoms From Baseline Using the Simpson Angus Scale (SAS)","description":"The minimum possible score is 0 and the maximum score is 4. A higher score implies a worse condition.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-.04","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in Body Weight From Baseline","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":".83","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Who Fell at Least Once During the Study","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"18","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in Appearance of Extrapyramidal Symptoms From Baseline Using the Abnormal Involuntary Movement Scale (AIMS)","description":"The minimum possible score is 0 and the maximum score is 4. A higher score implies a worse condition.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-.79","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in or Appearance of Extrapyramidal Symptoms From Baseline Using the Barnes Akathisia Scale (BAS)","description":"The minimum possible score is 0 and the maximum score is 5. A higher score implies a worse condition.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-.53","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Who Had a Fall That Required Medical Attention","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants Who Had a Fall That Required Medical Attention and Was Related to Lamotrigine","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":2,"n":57},"commonTop":["Fall","Weight gain","Weight Loss","Rash","Vomiting"]}}}